UTHR
A boardroom goodbye
United Therapeutics is waving goodbye to a familiar face: Professor Raymond Dwek, who’s set to leave the board when the company holds its annual meeting on June 26, 2026. He’s been on the board since 2002, which in corporate years is basically a lifetime.
Why you should care
This isn’t the kind of headline that sends traders sprinting for the exits, but board changes can still matter. Directors help shape oversight, strategy, and the occasional CEO reality check, so a long-tenured departure can nudge investors to ask whether the company is refreshing its governance playbook or just following a routine rotation.
The fine print
- Dwek’s term expires at the 2026 Annual Meeting of Shareholders
- The meeting is scheduled for June 26, 2026
- He joined the board back in 2002, so this is clearly a planned exit rather than a sudden shake-up
Big picture: this looks more like a housekeeping update than a corporate soap opera, but long-serving board exits are still worth a glance if you’re watching how a company is steering itself.